Zeolite and sea plasma nutritional supplement

Abstract

A zeolite and sea plasma nutritional supplement that includes an effective concentration of a zeolite and an effective concentration of a sea plasma. The effective concentration of the zeolite and the effective concentration of the sea plasma are mixed together to form the zeolite and sea plasma nutritional supplement. When consumed by a human body, the zeolite and sea plasma nutritional supplement reduces a concentration of forever chemicals in the human body.

Description

ZEOLITE AND SEA PLASMA NUTRITIONAL SUPPLEMENTREFERENCE TO RELATED APPLICATION

[0001] This application claims priority to Provisional Applic. No. 63 / 632,044, filed April 10, 2024, the contents of which are incorporated herein by reference.FIELD OF THE INVENTION

[0002] The invention relates generally to nutritional supplements. More particularly, the invention relates to a zeolite and sea plasma nutritional supplement.BACKGROUND OF THE INVENTION

[0003] It is recognized that forever chemicals pose health risks when consumed by humans. Humans are exposed to forever chemicals such as by ingestion (drinking or eating) or inhalation (breathing).

[0004] Exposure is most common for persons who work at or live near locations where the forever chemicals are processed. An example of one type of forever chemical is heavy metals such as arsenic, barium, cadmium, chromium, lead, mercury, selenium, and silver.SUMMARY OF THE INVENTION

[0005] An embodiment of the invention is directed to a zeolite and sea plasma nutritional supplement that includes an effective concentration of a zeolite and an effective concentration of a sea plasma. The effective concentration of the zeolite and the effective concentration of the sea plasma are mixed together to form the zeolite and sea plasma nutritional supplement. Whenconsumed by a human body, the zeolite and sea plasma nutritional supplement reduces a concentration of forever chemicals in the human body.

[0006] Another embodiment of the invention is directed to a method of preparing a zeolite and sea plasma nutritional supplement. A zeolite and concentrated acid solution is prepared. The zeolite and concentrated acid solution is stirred until substantially all of the zeolite dissolves. The zeolite and concentrated acid solution is heated to dissolve a significant portion of the concentrated acid and form a reduced particle size zeolite mixture. The reduced particle size zeolite mixture is mixed with sea plasma to form a zeolite and sea plasma solution. The zeolite and sea plasma solution is mixed with purified water to form the zeolite and sea plasma nutritional supplement.

[0007] Another embodiment of the invention is directed to a method of reducing a concentration of forever chemicals in a human body. A zeolite and sea plasma nutritional supplement is prepared by first mixing a zeolite and concentrated acid to form a solution. The zeolite and concentrated acid solution is stirred until substantially all of the zeolite dissolves. The zeolite and concentrated acid solution is heated to dissolve a significant portion of the concentrated acid and form a reduced particle size zeolite mixture. The reduced particle size zeolite mixture is mixed with sea plasma to form a zeolite and sea plasma solution. The zeolite and sea plasma solution is mixed with purified water to form the zeolite and sea plasma nutritional supplement. The zeolite and sea plasma nutritional supplement is administered to a human body through a body orifice.DETAILED DESCRIPTION OF THE INVENTION

[0008] An embodiment of the invention is directed to a nutritional supplement that is effective after being consumed to reduce a concentration of forever chemicals such as heavy metalsin a human body. The nutritional supplement is a solution that generally includes an effective concentration of a zeolite and an effective concentration of sea plasma.

[0009] As used herein, effective at reducing the concentration of the forever chemical in the human body means that a concentration of the forever chemical is reduced by greater than about 50 percent by weight. In other embodiments, the concentration of the forever chemical is reduced by greater than about 80 percent by weight. In still other embodiments, the concentration of the forever chemical is reduced by about 94 percent by weight.

[0010] An important aspect on the ability of the nutritional supplement to reduce the forever chemical concentration in a body is that the forever chemical have a positive surface charge. Non-limiting examples of forever chemicals that the nutritional supplement is effective include graphene oxide 2D-nano, polyethylene glycol, perfluorooctanesulfonic acid, perfluorooctanoic acid, polypropylene, polyethylene, perfluorooctanoic acid, iron, aluminum, lead, mercury, titanium, arsenic, glyphosate, phosgene, atrazine, cesium- 137, plutonium -239, dioxane, barium, titanium dioxide, aspergillus, bisphenol-A, all types of fluoride, methyl mercury (food source), thimerosal and aluminum oxide.

[0011] As described in more detail herein, the zeolite is in certain embodiments a nanometer sized natural clinoptilolite and the sea plasma is a structured subnanometer colloidal sea plasma solution.

[0012] In certain embodiments, the zeolite is a clinoptilolite. A person of skill in the art will appreciate that other zeolites that are generally recognized as safe for human consumption may be utilized in the nutritional supplement.

[0013] To enhance the effectiveness of the invention when consumed, a particle size of the zeolite is reduced. The reduced zeolite particle size also enhances the stability of the product whilestored prior to use. In certain embodiments, the zeolite has an average particle size of less than about 100 nanometers. In other embodiments, the zeolite has an average particle size of less than about 1 nanometer. In still other embodiments, the zeolite has an average particle size of less than about 0.01 nanometers.

[0014] As an initial step in preparing the nutritional supplement, the zeolite is dissolved in a concentrated acid. The volume of the concentrated acid in which the zeolite is dissolved is sufficiently large such that substantially all of the zeolite dissolves.

[0015] In certain embodiments, the concentrated acid is HC1. As used herein, concentrated means that the acid has a concentration of greater than about 5M. In other embodiments, the concentration of acid is 12M. A person of skill in the art will appreciate that other acids may be used in conjunction with the invention.

[0016] About 200 grams of clinoptilolite is added to about 500 milliliters of 12M HC1 to form a zeolite mixture. The zeolite mixture is stirred for an extended period of time. The extended period of time should be sufficiently long such that the clinoptilolite substantially dissolves.

[0017] In certain embodiments, the extended period of time is at least about 5 hours. In other embodiments, the extended period of time is between about 5 hours and about 20 hours. In still other embodiments, the extended period of time is about 12 hours.

[0018] A person of skill in the art will appreciate that a variety of equipment may be used for dissolving the zeolite. An example of one suitable equipment for dissolving the zeolite is a magnetic stirring tray.

[0019] While stirring, the zeolite mixture is heated. In certain embodiments, the heating is at a temperature of greater than about 200 °C. In other embodiments, the temperature is between about 200 °C and about 400 °C. In still other embodiments, the temperature is about 280 °C.

[0020] The heating causes a significant portion of the concentrated acid to evaporate from the mixture. In certain embodiments, the heating removes substantially all of the concentrated acid. As used herein, removing substantially all of the concentrated acid means that the magnetic stirrer cannot stir any more.

[0021] The dissolving of the zeolite in the concentrated acid and heating of the zeolite mixture causes a reduction of the particle size of the zeolite.

[0022] The reduced particle size zeolite mixture is then added to sea plasma. In certain embodiments, the sea plasma is living structured sea plasma.

[0023] The sea plasma may be cooled prior to mixing with the reduced particle size zeolite mixture. In certain embodiments, the sea plasma is cooled to a temperature of less than about 20°C prior to being mixed with the reduced particle size zeolite mixture. In other embodiments, the sea plasma is cooled to about 1°C prior to being mixed with the reduced particle size zeolite mixture.

[0024] A relatively small concentration of the reduced particle size zeolite mixture is mixed with the cooled sea plasma. In certain embodiments, about 200 grams of reduced particle size zeolite mixture is mixed with greater than about 1 gallon of the cooled sea plasma. In other embodiments, about 200 grams of the reduced particle size zeolite mixture is mixed with between about 2 gallons and about 10 gallons of the cooled sea plasma. In still other embodiments, about 200 grams of the reduced particle size zeolite is mixed with about 5 gallons of the cooled sea plasma.

[0025] The zeolite sea plasma solution is then diluted with purified water. As used herein, purified water means water that is substantially depleted of minerals and other materials. Using purified water minimizes and / or avoids disturbing the charge of the zeolite. In certainembodiments, the purified water is distilled water. In other embodiments, the purified water is double distilled water.

[0026] A concentration of the purified water is less than a concentration of the zeolite sea plasma solution. In certain embodiments, 1 part of the zeolite sea plasma solution is mixed with greater than about 1 part of the purified water. In other embodiments, 1 part of the zeolite sea plasma solution is mixed with between about 2 parts and about 5 parts of the purified water. In still other embodiments, 1 part of the zeolite sea plasma solution is mixed with about 2 parts of the purified water.

[0027] Mixing of the zeolite sea plasma solution and the purified water may be done in a manner that minimizes molecular clustering of the zeolite solution. An example of one suitable technique that may be used for mixing together the zeolite sea plasma solution and the purified water utilizes vortexing.

[0028] The vortexing may be achieved using a 14 inch structuring device that is used in conjunction with a pump which is pumping at a rate of about 8.5 gallons per minute. Using such a device causes the mixing of the zeolite sea plasma solution and the purified water to be done at an elevated pressure.

[0029] Mixing the zeolite sea plasma solution and the purified water utilizing the preceding conditions creates a structured colloidal solution, which maintains a negative surface charge of the zeolite particles while the product is stored prior to use. Such properties substantially prevent the zeolite from falling out of solution while the product is stored prior to use.

[0030] The nutritional supplement may be stored in a sealed container for an extended period of time while the nutritional supplement retains its effectiveness. The nutritional supplement is intended for consumption through at least one body orifice. For example, thenutritional supplement may be consumed sublingually. Additional examples of techniques for consuming the nutritional supplement include through the nose and eyes. The nutritional supplement may be dispensed from the container using a variety of techniques. An example of one suitable technique is in the form of drops.

[0031] The nutritional supplement is consumed at an effective dose on a daily basis. The effective dose may be up to about 10 drops. In other embodiments, the effective dose is about 5 drops. When consumed on a regular basis, the nutritional supplement causes a reduction of the forever chemicals (such as heavy metal) concentration in the body. For persons with an elevated forever chemical concentration, the dosage may be increased.

[0032] In certain embodiments, the nutritional supplement is administered at a volume of between about 1 drop and about 20 drops per day for a person having a weight if about 70 kilograms. As used herein, a drop has a volume of about 0.05 milliliters. The amount of the nutritional supplement that is consumed may be increased or decreased based upon the weight of the person consuming the nutritional supplement.

[0033] In other embodiments, the nutritional supplement is administered at a volume of between about 5 drops and about 15 drops per day for a person having a weight of about 70 kilograms. In still other embodiments, the nutritional supplement is administered at a volume of about 10 drops per day for a person having a weight of about 70 kilograms.

[0034] In certain embodiments, the nutritional supplement is consumed on a daily basis. While it is possible for the nutritional supplement to be consumed all at once, in certain embodiments, a portion of the nutritional supplement is consumed at different times during the day. For example, about !4 of the daily volume of the nutritional supplement is consumed in the morning and about i of the daily volume of the nutritional supplement is consumed in the evening.

[0035] The person may begin by consuming a relatively small daily amount of the nutritional supplement such as 1 drop. Over a period of time such as between about 7 days and about 30 days, the daily volume administered may be increased.

[0036] Each drop of the nutritional supplement contains between about 60 micrograms and about 200 micrograms of the zeolite. In other embodiments, each drop of the nutritional supplement contains between about 90 micrograms and about 150 micrograms of the zeolite.

[0037] Each drop of the nutritional supplement contains between about 25 microliters and about 75 microliters of the sea plasma. In other embodiments, each drop of the nutritional supplement contains between about 40 microliters and about 60 microliters of the sea plasma.

[0038] In still other embodiments, each drop of the nutritional supplement may include about 120 micrograms of the zeolite and may include about 50 microliters of sea plasma. As such, a daily dose of 10 drops of the nutritional supplement contains about 1,200 micrograms of zeolite and about 500 microliters of sea plasma.

[0039] The nutritional supplement reduces the intracellular concentration of forever chemicals. The performance of the nutritional supplement at reducing the intracellular concentration of forever chemicals is evaluated using intracellular electrical capacity examination.

[0040] In certain embodiments, the nutritional supplement causes a reduction in the concentration of forever chemicals in the human body of more than about 50 percent by weight when the nutritional supplement is administered for an effective period of time. In other embodiments, the nutritional supplement causes a reduction in the concentration of the forever chemicals in the human body of more than about 80 percent by weight when the nutritional supplement is administered for an effective period of time. In still other embodiments, the nutritional supplement causes a reduction in the concentration of the forever chemicals in thehuman body of about 94 percent by weight when the nutritional supplement is administered for an effective period of time.

[0041] With administration of the nutritional supplement on a daily basis, the reduction of the forever chemicals in the human body may take place over the effective period of time. This effective period of time may be greater than about 30 days. In other embodiments, the effective period of time is about 90 days.

[0042] It is possible for the person to continue administering the nutritional supplement for more than the effective period of time as such extended administration will prevent a concentration of forever chemicals in the person’s body from increasing caused from exposure to the forever chemicals that are present such as in food or beverages consumed by the person, in objects that come into contact with the person’s body and / or in gases that are breathed in by the person.

[0043] The nutritional supplement utilizes the positive surface charge of the forever chemicals to chelate the forever chemicals and through such a process, it is possible for the forever chemicals to be removed from the human body. The zeta potential of the forever chemical is also believed to play a role in the removal of the forever chemicals from the human body using the nutritional supplement. The relatively small size of the particles in the nutritional supplement also facilitates removal of the forever chemicals from the human body.

[0044] In the preceding detailed description, reference is made to the accompanying drawings, which form a part hereof, and in which is shown by way of illustration specific embodiments in which the invention may be practiced. In this regard, directional terminology, such as “top,” “bottom,” “front,” “back,” “leading,” “trailing,” etc., is used with reference to the orientation of the Figure(s) being described. Because components of embodiments can be positioned in a number of different orientations, the directional terminology is used for purposesof illustration and is in no way limiting. It is to be understood that other embodiments may be utilized and structural or logical changes may be made without departing from the scope of the present invention. The preceding detailed description, therefore, is not to be taken in a limiting sense, and the scope of the present invention is defined by the appended claims.

[0045] It is contemplated that features disclosed in this application, as well as those described in the above applications incorporated by reference, can be mixed and matched to suit particular circumstances. Various other modifications and changes will be apparent to those of ordinary skill.

Claims

CLAIMS1. A zeolite and sea plasma nutritional supplement comprising: an effective concentration of a zeolite; and an effective concentration of a sea plasma, wherein the effective concentration of the zeolite and the effective concentration of the sea plasma are mixed together to form the zeolite and sea plasma nutritional supplement and wherein when consumed by a human body, the zeolite and sea plasma nutritional supplement reduces a concentration of forever chemicals in the human body.

2. The zeolite and sea plasma nutritional supplement of claim 1, wherein the zeolite comprises natural clinoptilolite.

3. The zeolite and sea plasma nutritional supplement of claim 1, wherein the zeolite has an average particle size of less than about 0.01 nanometers.

4. The zeolite and sea plasma nutritional supplement of claim 1, wherein the effective concentration of the zeolite in the nutritional supplement is between about 90 micrograms and about 150 micrograms per drop of the nutritional supplement.

5. The zeolite and sea plasma nutritional supplement of claim 1, wherein the sea plasma comprises a structured subnanometer colloidal sea plasma solution.

6. The zeolite and sea plasma nutritional supplement of claim 1, wherein the effective concentration of the sea plasma is between about 40 microliters and about 60 microliters per drop of the nutritional supplement.

7. A method of preparing a zeolite and sea plasma nutritional supplement comprising: preparing a zeolite and concentrated acid solution; stirring the zeolite and concentrated acid solution until substantially all of the zeolite dissolves; heating the zeolite and concentrated acid solution to dissolve a significant portion of the concentrated acid and form a reduced particle size zeolite mixture; mixing the reduced particle size zeolite mixture with sea plasma to form a zeolite and sea plasma solution; and mixing the zeolite and sea plasma solution with purified water to form the zeolite and sea plasma nutritional supplement.

8. The method of preparing the zeolite and sea plasma nutritional supplement of claim 7, wherein substantially all of the zeolite dissolves in the concentrated acid.

9. The method of preparing the zeolite and sea plasma nutritional supplement of claim 7, wherein the concentrated acid is hydrochloric acid.

10. The method of preparing the zeolite and sea plasma nutritional supplement of claim 7, wherein the concentrated acid has a concentration of greater than about 5M.

11. The method of preparing the zeolite and sea plasma nutritional supplement of claim 7, wherein the heating of the zeolite and concentrated acid solution is to a temperature of between about 200°C and about 400°C.

12. The method of preparing the zeolite and sea plasma nutritional supplement of claim 7, wherein the particle size of the zeolite particles in the reduced particle size zeolite mixture is less than about 1 nanometer.

13. The method of preparing the zeolite and sea plasma nutritional supplement of claim 7, wherein the sea plasma comprises living structured sea plasma.

14. The method of preparing the zeolite and sea plasma nutritional supplement of claim 7, and further comprising cooling the sea plasma to a temperature of less than about 20°C prior to mixing the reduced particle size zeolite mixture and the sea plasma.

15. The method of preparing the zeolite and sea plasma nutritional supplement of claim 14, wherein about 200 grams of the reduced particle size zeolite mixture is mixed with between about 2 gallons and about 10 gallons of cooled sea plasma.

16. The method of preparing the zeolite and sea plasma nutritional supplement of claim 7, wherein about 1 part of the zeolite and sea plasma solution is mixed with between about 2 partsand about 5 parts of the purified water and wherein the purified water is substantially depleted of minerals and other materials.

17. The method of preparing the zeolite and sea plasma nutritional supplement of claim 7, wherein the mixing of the zeolite and sea plasma solution with the purified water utilizes vortexing to substantially avoid molecular clustering of the zeolite solution.

18. The method of preparing the zeolite and sea plasma nutritional supplement of claim 7, wherein the mixing of the zeolite and sea plasma solution with the purified water creates a structured colloidal solution, wherein the concentration of the zeolite in the nutritional supplement is between about 90 micrograms and about 150 micrograms per drop of the nutritional supplement and wherein the concentration of the sea plasma is between about 40 microliters and about 60 microliters per drop of the nutritional supplement.

19. A method of reducing a concentration of forever chemicals in a human body comprising: preparing a zeolite and sea plasma nutritional supplement that comprises: preparing a zeolite and concentrated acid solution; stirring the zeolite and concentrated acid solution until substantially all of the zeolite dissolves; heating the zeolite and concentrated acid solution to dissolve a significant portion of the concentrated acid and form a reduced particle size zeolite mixture; mixing the reduced particle size zeolite mixture with sea plasma to form a zeolite and sea plasma solution; andmixing the zeolite and sea plasma solution with purified water to form the zeolite and sea plasma nutritional supplement; and administering the zeolite and sea plasma nutritional supplement through a body orifice.

20. The method of reducing the concentration of forever chemicals in the human body of claim 19, wherein the body orifice is at least one of sublingually, nose and eyes.

21. The method of reducing the concentration of forever chemicals in the human body of claim 19, wherein the zeolite and sea plasma nutritional supplement is consumed at a dosage of between about 5 drops and about 10 drops per day, wherein the concentration of the zeolite in the nutritional supplement is between about 90 micrograms and about 150 micrograms per drop of the nutritional supplement and wherein the concentration of the sea plasma is between about 40 microliters and about 60 microliters per drop of the nutritional supplement.